City

Bangkok (1)

Taoyuan (1)

Condition

Immunogenicity (2)

Reactogenicity (2)

Covid-19 (1)

Healthy (1)

Vaccine (1)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Chang Gung Memorial Hospital (1)

Queen Sirikit National Institute of Child Health (1)

Collaborator

Intervention

heterologous prime-boost schedule with azd1222 and mvc-cov1901 (1)

homologous prime-boost schedule with two doses of azd1222 (1)

trivivac vaccine (1)

Study Documents

Intervention Type

biological (2)

Funder Type

Other (2)

Study Type

Interventional (2)

reactogenicity

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Covid-19, Vaccine, Immunogenicity Trial in Taoyuan (Heterologous prime-boost schedule with AZD1222 and MVC-COV1901, Homologous

Recruiting

Covid-19
+4 more

Heterologous prime-boost schedule with AZD1222 and MVC-COV1901
Homologous prime-boost schedule with two doses of AZD1222

Taoyuan, Taiwan

ChangGungMH

Oct 19, 2021

Immunogenicity, Reactogenicity Trial in Bangkok (Trivivac vaccine)

Unknown status

Immunogenicity
Reactogenicity

Trivivac vaccine

Bangkok, Thailand

Queen Sirikit National Institute of Child Health

Jan 5, 2013